- Home
- NUTX vs MDXG Comparison
NUTX vs MDXG Comparison
Compare NUTX & MDXG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NUTX
- MDXG
- Stock Information
- Founded
- NUTX 2011
- MDXG 2006
- Country
- NUTX United States
- MDXG United States
- Employees
- NUTX N/A
- MDXG N/A
- Industry
- NUTX Retail: Computer Software & Peripheral Equipment
- MDXG Biotechnology: Pharmaceutical Preparations
- Sector
- NUTX Technology
- MDXG Health Care
- Exchange
- NUTX Nasdaq
- MDXG Nasdaq
- Market Cap
- NUTX 967.1M
- MDXG 999.9M
- IPO Year
- NUTX N/A
- MDXG N/A
- Fundamental
- Price
- NUTX $118.81
- MDXG $5.98
- Analyst Decision
- NUTX Strong Buy
- MDXG Strong Buy
- Analyst Count
- NUTX 2
- MDXG 2
- Target Price
- NUTX $262.50
- MDXG $12.50
- AVG Volume (30 Days)
- NUTX 144.8K
- MDXG 517.2K
- Earning Date
- NUTX 08-07-2025
- MDXG 07-30-2025
- Dividend Yield
- NUTX N/A
- MDXG N/A
- EPS Growth
- NUTX N/A
- MDXG N/A
- EPS
- NUTX 12.01
- MDXG 0.27
- Revenue
- NUTX $624,284,633.00
- MDXG $352,375,000.00
- Revenue This Year
- NUTX $65.82
- MDXG $9.55
- Revenue Next Year
- NUTX $4.98
- MDXG $11.43
- P/E Ratio
- NUTX $9.72
- MDXG $21.55
- Revenue Growth
- NUTX 141.25
- MDXG 5.34
- 52 Week Low
- NUTX $4.16
- MDXG $5.47
- 52 Week High
- NUTX $184.28
- MDXG $10.14
- Technical
- Relative Strength Index (RSI)
- NUTX 39.00
- MDXG 31.75
- Support Level
- NUTX $117.20
- MDXG $5.80
- Resistance Level
- NUTX $136.81
- MDXG $6.60
- Average True Range (ATR)
- NUTX 12.17
- MDXG 0.17
- MACD
- NUTX -3.96
- MDXG -0.05
- Stochastic Oscillator
- NUTX 9.03
- MDXG 11.25
About NUTX Nutex Health Inc.
Nutex Health Inc is healthcare services and operations company with 20 hospital facilities in eight states (hospital division), and a primary care-centric, risk-bearing population health management division. The hospital division implements and operates healthcare models, including micro-hospitals, specialty hospitals and hospital outpatient departments (HOPDs). The population health management division owns and operates provider networks such as independent physician associations (IPAs) and offers a cloud-based proprietary technology platform to IPAs that aggregates clinical and claims data across multiple settings, information systems and sources to create a holistic view of patients and providers.
About MDXG MiMedx Group Inc
MiMedx Group Inc develops and markets regenerative biomaterial products and bioimplants made from the human amniotic membrane, birth tissues, and human skin & bone. Its products are primarily targeted towards the wound-care, burn, surgical, sports medicine, and orthopedics markets. MiMedx's key products are allografts processed from amniotic tissue, which include EpiFix for external use and AmnioFix for internal use. AmnioCord, AmnioFill, EpiBurn, and EpiCord are some of its other products. Also, it sells allografts for ophthalmic surgery and dental applications through licenses to third parties.